Luke K. Plumpton
phone: (248) 554-4215
Mr. Plumpton is a private equity executive with over 15 years of M&A, investment banking and operational management team experience. He is responsible for evaluating, structuring, negotiating and financing transactions, as well as monitoring O2's portfolio companies.
Former Director of Strategic Planning for Hanford Pharmaceuticals, Senior Associate at Square 1 Bank and Analyst at Wells Fargo Securities (Healthcare Investment Banking Group). Mr. Plumpton's experiences range from leading companies through divestiture plans during the recession to deal facilitation for M&A, debt and equity transactions for both publicly traded and private companies to managing the build out of a boutique venture debt bank. He has completed in excess of 30 deals in the form of M&A sell side/buy side, IPOs, Follow-on equity offerings, I-grade and High Yield bonds, equity private placements and several hundred million dollars of Loan Syndications.
Mr. Plumpton serves on the boards of O2's portfolio businesses: Clio Holdings (Director), CCSI Networks (Vice Chairman), National Technologies (Vice Chairman), Precision Made Products (Director), PCT Brands (Vice Chairman), Alpha Sintered Metals (Director), Precision Compacted Components (Director), O2 Specialty Manufacturing (Board Observer), Packaging Concepts & Design (Director) and former Board Observer of Greco Aluminum Railings.
Mr. Plumpton received his BA in economics from Harvard University, where he graduated with honors and was a member of the varsity lacrosse team. While attending Harvard, Mr. Plumpton also studied Corporate Accounting at MIT's Sloan Business School.